CRP was sufficiently reduced by prior treatments before the introduction of mepolizumab, and IgE showed a decreasing trend throughout the course of treatment.
← all excerpts
Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
1
—
—